Cellyan Biotechnology Co., Ltd (HKPD)
Nasdaq: HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries · filing with the SEC since 2024
Who owns Cellyan Biotechnology Co., Ltd
As filed with the SECHolders of 5% or more
4
Liying Wang holds 65% of Ordinary Shares, par value $0.001 per share, as its SCHEDULE 13D filed Nov 12, 2025 says.
Directors and officers
7
report now, of 7 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Liying Wang
SCHEDULE 13D · filed Nov 12, 2025 · Ordinary Shares, par value $0.001 per share
Lap Sun Wong
SCHEDULE 13G · filed Jun 3, 2025 · Ordinary Shares, $0.001 par value
Atlantic Health Century International Group
SCHEDULE 13G · filed Jun 5, 2025 · Ordinary Shares, $0.001 par value
Pacific Health Century International Group
SCHEDULE 13G · filed Jun 5, 2025 · Ordinary Shares, $0.001 par value
What HKPD reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 20-F filed Aug 7, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.